摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetamide | 807342-27-4

中文名称
——
中文别名
——
英文名称
(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetamide
英文别名
[(3R,4S)-4-(4-chlorophenyl)-piperidin-3-ylmethylsulfanyl]-acetamide;2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetamide
(+)-2-[[(3R,4S)-4-(4-chlorophenyl)piperidin-3-yl]methylsulfanyl]acetamide化学式
CAS
807342-27-4
化学式
C14H19ClN2OS
mdl
——
分子量
298.837
InChiKey
ZAVZXAPSKRLFJQ-DGCLKSJQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    486.9±45.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    80.4
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] DOPAMINE-, NOREPINEPHRINE- AND SEROTONIN- TRANSPORTER- SELECTIVE HETEROCYCLIC COMPOUNDS AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] COMPOSES HETEROCYCLIQUES SELECTIFS VIS-A-VIS DES TRANSPORTEURS DE LA DOPAMINE, DE LA NOREPINEPHRINE ET DE LA SEROTONINE ET LEURS APPLICATIONS THERAPEUTIQUES
    申请人:UNIV GEORGETOWN
    公开号:WO2005041875A3
    公开(公告)日:2005-11-24
  • DOPAMINE-, NOREPINEPHRINE- AND SEROTONIN- TRANSPORTER- SELECTIVE HETEROCYCLIC COMPOUNDS AND THEIR THERAPEUTIC APPLICATIONS
    申请人:GEORGETOWN UNIVERSITY
    公开号:EP1680113A2
    公开(公告)日:2006-07-19
  • Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
    申请人:Kozikowski P. Alan
    公开号:US20070254918A1
    公开(公告)日:2007-11-01
    One aspect of the invention relates to piperidine compounds that are useful as inhibitors of monoamine transporters. The invention also relates to pharmaceutical compositions, comprising a piperidine compound of the invention. Another aspect of the present invention relates to the use of the aforementioned compounds in a method of treating a disorder of the central nervous system in a mammal.
  • US8153657B2
    申请人:——
    公开号:US8153657B2
    公开(公告)日:2012-04-10
  • Piperidine-Based Nocaine/Modafinil Hybrid Ligands as Highly Potent Monoamine Transporter Inhibitors:  Efficient Drug Discovery by Rational Lead Hybridization
    作者:Jia Zhou、Rong He、Kenneth M. Johnson、Yanping Ye、Alan P. Kozikowski
    DOI:10.1021/jm040117o
    日期:2004.11.1
    Some piperidine-based nocaine/modafinil hybrid ligands have been designed, synthesized, and found to display an improved potency at all three monoamine transporters and particularly for DAT and/or NET. Some highly active and selective monoamine transporter inhibitors with low nanomolar to subnanomolar potency were identified. Ligands of this type may find important applications as positron emission tomography imaging tools and in the treatment of central nervous system disorders such as depression and sleep apnea.
查看更多